Monday 3rd March 2014 |
Text too small? |
Transpacific Industries Group, the Australian waste management company, agreed to sell its New Zealand business to Beijing Capital Group for $950 million, raising cash to repay debt.
The Queensland-based company hired Deutsche Bank in October to advise on the sale of its New Zealand unit, to focus on its more profitable Australian business. It wrote down the value of the kiwi business by A$188 million in 2011 after acquiring the operations for $870 million in 2006.
The company's decision to scale back its business comes after a debt-fuelled expansion before the global financial crisis, culminating in 2008 with the A$1.25 billion acquisition of rival Cleanaway to create Australasia's biggest waste disposal firm.
"The sale of our New Zealand business gives Transpacific increased financial flexibility," said Robert Boucher, the company's chief executive. "Beijing Capital is focused on investing in and developing the New Zealand business."
Beijing Capital is a Chinese state-owned specialist in water treatment, waste management, mass transit railways and toll roads, as well as one of China's most prominent real estate developers. Its assets are valued at US$21 billion.
Transpacific said proceeds from the sale will be used to redeem its Step-Up Preference Securities, refinance debt and fund future investments. The company will consider the resumption of dividends in the near future, it said.
The dual-listed shares rarely trade on the NZX and were unchanged at $1.40, having declined 84 percent in the past 12 months. On the ASX they last traded at A$1.175, and have gained 29 percent in the past year.
The deal is expected to be completed mid-year, subject to Overseas Investment Office and Chinese regulatory approvals.
BusinessDesk.co.nz
No comments yet
December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors